Achieve Life Sciences, Inc. Increase (Decrease) in Prepaid Expense
Achieve Life Sciences, Inc. (ACHV) reported Increase (Decrease) in Prepaid Expense of -$140.00 thousand for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2013-08-08
- Achieve Life Sciences, Inc. increase (decrease) in prepaid expense for the quarter ending 2013-06-30 was $230.00K, a 96.34% decline year-over-year.
- Achieve Life Sciences, Inc. increase (decrease) in prepaid expense for the quarter ending 2013-03-31 was -$370.00K, a 142.58% decline year-over-year.
- Achieve Life Sciences, Inc. increase (decrease) in prepaid expense for the quarter ending 2012-12-31 was -$6.31M.
- Achieve Life Sciences, Inc. increase (decrease) in prepaid expense for the quarter ending 2012-09-30 was $1.55M, a 20.71% decline year-over-year.
- Achieve Life Sciences, Inc. increase (decrease) in prepaid expense for fiscal 2012 was $2.39M.
- Achieve Life Sciences, Inc. increase (decrease) in prepaid expense for fiscal 2011 was -$1.27M, a 172.32% decline from fiscal 2010.
- Achieve Life Sciences, Inc. increase (decrease) in prepaid expense for fiscal 2010 was $1.76M, a 1196.32% increase from fiscal 2009.
- Achieve Life Sciences, Inc. increase (decrease) in prepaid expense for fiscal 2009 was $136.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month | Increase (Decrease) in Prepaid Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2013-06-30 | $230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$140.00K 10-Q · filed 2013-08-08 | -$6.45M derived: sum of 3 quarters · filed 2013-08-08 | -$4.90M derived: sum of 4 quarters · filed 2013-08-08 | |
| 2013-03-31 | -$370.00K 10-Q · filed 2013-05-02 | -$6.68M derived: sum of 2 quarters · filed 2013-05-02 | -$5.13M derived: sum of 3 quarters · filed 2013-05-02 | $1.16M derived: sum of 4 quarters · filed 2013-08-08 | |
| 2012-12-31 | -$6.31M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | -$4.76M derived: sum of 2 quarters · filed 2013-03-07 | $1.52M derived: sum of 3 quarters · filed 2013-08-08 | $2.39M 10-K · filed 2013-03-07 | |
| 2012-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $7.84M derived: sum of 2 quarters · filed 2013-08-08 | $8.71M 10-Q · filed 2012-11-08 | $6.57M derived: sum of 4 quarters · filed 2013-08-08 | |
| 2012-06-30 | $6.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $7.15M 10-Q · filed 2013-08-08 | $5.01M derived: sum of 3 quarters · filed 2013-08-08 | $6.97M derived: sum of 4 quarters · filed 2013-08-08 | |
| 2012-03-31 | $869.00K 10-Q · filed 2013-05-02 | -$1.27M derived: sum of 2 quarters · filed 2013-05-02 | $685.00K derived: sum of 3 quarters · filed 2013-05-02 | $1.11M derived: sum of 4 quarters · filed 2013-05-02 | |
| 2011-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | -$184.00K derived: sum of 2 quarters · filed 2013-03-07 | $244.00K derived: sum of 3 quarters · filed 2013-03-07 | -$1.27M 10-K · filed 2013-03-07 | -$1.28M 10-K · filed 2012-03-08 |
| 2011-09-30 | $1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $2.38M derived: sum of 2 quarters · filed 2012-11-08 | $865.00K 10-Q · filed 2012-11-08 | $2.32M derived: sum of 4 quarters · filed 2013-03-07 | |
| 2011-06-30 | $428.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$1.09M 10-Q · filed 2012-08-02 | $364.00K derived: sum of 3 quarters · filed 2013-03-07 | -$947.00K derived: sum of 4 quarters · filed 2013-03-07 | |
| 2011-03-31 | -$1.52M 10-Q · filed 2012-05-03 | -$64.00K derived: sum of 2 quarters · filed 2013-03-07 | -$1.38M derived: sum of 3 quarters · filed 2013-03-07 | ||
| 2010-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $144.00K derived: sum of 2 quarters · filed 2013-03-07 | $1.76M 10-K · filed 2013-03-07 | ||
| 2010-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $308.00K 10-Q · filed 2011-11-03 | |||
| 2010-06-30 | $1.62M 10-Q · filed 2011-08-05 | ||||
| 2009-12-31 | $136.00K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |